These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1784579)

  • 1. Assessment of triethanolamine salicylate release from the dermatological bases and the commercial products.
    Babar A; Chickhale PJ; Plakogiannis FM
    Pharm Acta Helv; 1991; 66(12):322-8. PubMed ID: 1784579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro release studies of methyl salicylate from the ointment bases and the commercial dermatological products.
    Barbar A; Raouf M; Plakogiannis FM
    Pharm Acta Helv; 1990; 65(5-6):170-4. PubMed ID: 2371308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents.
    Casiraghi A; Ardovino P; Minghetti P; Botta C; Gattini A; Montanari L
    Arch Dermatol Res; 2007 Jul; 299(4):201-7. PubMed ID: 17370081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The dynamics of the drug release from ointment bases. Part 5: The effects of tensides on the liberation of atropine from eye ointments (author's transl)].
    Pasich J; Bether W; Malaga M
    Pharmazie; 1981 Apr; 36(4):267-9. PubMed ID: 7255527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro release and diffusion studies of promethazine hydrochloride from polymeric dermatological bases using cellulose membrane and hairless mouse skin.
    Babar A; Ray SD; Patel NK; Plakogiannis FM; Gogineni P
    Drug Dev Ind Pharm; 1999 Feb; 25(2):235-40. PubMed ID: 10065358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the release and efficacy of two new antibacterial agents from different ointment bases.
    el-Faham TH; Shawky S; abd el-Meguid E
    Pharmazie; 1989 Mar; 44(3):211-4. PubMed ID: 2748707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
    Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
    Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liberation of hydrocortisone acetate from different commercial formulations].
    Neubert RH; Pötzsch A
    Pharmazie; 2004 Jun; 59(6):472-4. PubMed ID: 15248463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams.
    Souto EB; Müller RH
    Pharmazie; 2007 Jul; 62(7):505-9. PubMed ID: 17718190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
    Realdon N; Tagliaboschi A; Perin F; Ragazzi E
    Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability.
    Smith EW; Meyer E; Haigh JM
    Arzneimittelforschung; 1990 May; 40(5):618-21. PubMed ID: 2383308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agents.
    Bikowski J; Shroot B
    J Drugs Dermatol; 2006; 5(10):942-6. PubMed ID: 17373142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel skin penetration enhancer: evaluation by membrane diffusion and confocal microscopy.
    Saunders J; Davis H; Coetzee L; Botha S; Kruger A; Grobler A
    J Pharm Pharm Sci; 1999; 2(3):99-107. PubMed ID: 10953256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro release studies of flurbiprofen from different topical formulations.
    el Gendy AM; Jun HW; Kassem AA
    Drug Dev Ind Pharm; 2002 Aug; 28(7):823-31. PubMed ID: 12236068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topical preparations for burns and their evaluation].
    Ducková K; Kucera J
    Ceska Slov Farm; 1998 May; 47(3):119-23. PubMed ID: 9650369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
    Baboota S; Shakeel F; Kohli K
    Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.